Literature DB >> 7216452

Rabbit tumor necrosis factor: mechanism of action.

M R Ruff, G E Gifford.   

Abstract

Rabbit tumor necrosis factor (TNF) was examined for effects on normal and transformed cells in culture. Several assays for killing of L-929 cell targets were developed, and their sensitivities were compared. Normal cells were not killed by TNF, and the discrimination between normal and transformed cells was shown not to be due to a cell cycle-dependent mechanism. TNF killing of L-929 cells was delayed for 10 to 12 h and thereafter showed concentration and time-dependent increases in cytolysis. Actinomycin D or cycloheximide treatment of L-929 cells resulted in an enhancement of the rate of cell killing as well as a shortening of the preceding lag period. TNF killing of L-929 cells was temperature dependent; cells were considerably more resistant to lysis at 25 degrees C and showed enhanced killing at 39 degrees C as compared to 37 degrees C controls. The slope of the dose curve showed less than single-hit kinetics. A model for cell killing whose general features incorporate both the specificity and catalytic properties of an enzymatic reaction is proposed for TNF action.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7216452      PMCID: PMC351794          DOI: 10.1128/iai.31.1.380-385.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Alteratons in RNA synthesis in lymphotoxin-treated target cells.

Authors:  G Kunitomi; W Rosenau; G C Burke; M L Goldberg
Journal:  Am J Pathol       Date:  1975-08       Impact factor: 4.307

2.  Binding of human lymphotoxin to target-cell membranes and its relation to cell-mediated cytodestruction.

Authors:  D A Hessinger; R A Daynes; G A Granger
Journal:  Proc Natl Acad Sci U S A       Date:  1973-11       Impact factor: 11.205

3.  Requirement for a serum component in cytotoxin ("lymphotoxin")-mediated target cell lysis.

Authors:  R B Lies
Journal:  Cell Immunol       Date:  1974-10       Impact factor: 4.868

4.  Early biochemical alterations induced by lymphotoxin in target cells.

Authors:  W Rosenau; M L Goldberg; G C Burke
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

5.  Quantitative studies of antigen expression in cultured murine lymphoma cells. I. Cell-surface antigens in "Asynchronous" cultures.

Authors:  M Cikes; G Klein
Journal:  J Natl Cancer Inst       Date:  1972-12       Impact factor: 13.506

6.  The interferon dose response curve and its possible significance.

Authors:  G E Gifford; A L Koch
Journal:  J Theor Biol       Date:  1969-02       Impact factor: 2.691

7.  Lymphocyte in vitro cytotoxicity: mechanism of lymphotoxin-induced target cell destruction.

Authors:  T W Williams; G A Granger
Journal:  J Immunol       Date:  1969-04       Impact factor: 5.422

8.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

9.  An improved in vitro assay for lymphotoxin.

Authors:  J J Kramer; G A Granger
Journal:  Cell Immunol       Date:  1972-01       Impact factor: 4.868

10.  Cytotoxic activity of lymphocytes. II. Studies on mechanism of lymphotoxin-mediated cytotoxicity.

Authors:  S M Walker; Z J Lucas
Journal:  J Immunol       Date:  1972-12       Impact factor: 5.422

View more
  40 in total

1.  Actinobacillus actinomycetemcomitans serotype b-specific polysaccharide antigen stimulates production of chemotactic factors and inflammatory cytokines by human monocytes.

Authors:  N Yamaguchi; Y Yamashita; D Ikeda; T Koga
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Antibodies against amino acids 1-15 of tumor necrosis factor block its binding to cell-surface receptor.

Authors:  S H Socher; M W Riemen; D Martinez; A Friedman; J Tai; J C Quintero; V Garsky; A Oliff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

3.  Polymorphisms in human heat shock factor-1 and analysis of potential biological consequences.

Authors:  Tiffany M Bridges; Rachel G Scheraga; Mohan E Tulapurkar; Dante Suffredini; Stephen B Liggett; Aparna Ramarathnam; Ratnakar Potla; Ishwar S Singh; Jeffrey D Hasday
Journal:  Cell Stress Chaperones       Date:  2014-07-16       Impact factor: 3.667

4.  The role of monocyte cytotoxic factor in monocyte-mediated lysis of tumour cells.

Authors:  T Espevik; O Kildahl-Andersen; J Nissen-Meyer
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

5.  Signalling pathway of tumor necrosis factor in normal and tumor cells.

Authors:  N Watanabe; H Neda; Y Ohtusuka; H Sone; N Yamauchi; M Maeda; H Kuriyama; Y Niitsu
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

6.  Antimetastatic effect of endogenous tumor necrosis factor induced by the treatment of recombinant interferon gamma followed by an analogue (GLA-60) to synthetic lipid A subunit.

Authors:  I Saiki; H Maeda; J Murata; N Yamamoto; M Kiso; A Hasegawa; I Azuma
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  IgA and IgG immune complexes increase human macrophage C3 biosynthesis.

Authors:  J Laufer; H Boichis; N Farzam; J H Passwell
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

8.  Tumor necrosis factor production by human sarcoid alveolar macrophages.

Authors:  P R Bachwich; J P Lynch; J Larrick; M Spengler; S L Kunkel
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

9.  Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta production.

Authors:  K D Chavin; L Qin; J Lin; J E Woodward; P Baliga; J S Bromberg
Journal:  Ann Surg       Date:  1993-10       Impact factor: 12.969

10.  The different effects of recombinant human tumor necrosis factor on rat fibrosarcoma sublines.

Authors:  J Ishihara; N Saijo; Y Sasaki; H Nakano; A Ozaki; H Takahashi; M Sakurai; K Nakagawa; M Iigo; F Kanzawa
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.